1. Home
  2. BHRB vs MESO Comparison

BHRB vs MESO Comparison

Compare BHRB & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHRB
  • MESO
  • Stock Information
  • Founded
  • BHRB 1852
  • MESO 2004
  • Country
  • BHRB United States
  • MESO Australia
  • Employees
  • BHRB N/A
  • MESO N/A
  • Industry
  • BHRB Major Banks
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BHRB Finance
  • MESO Health Care
  • Exchange
  • BHRB Nasdaq
  • MESO Nasdaq
  • Market Cap
  • BHRB 1.0B
  • MESO 1.2B
  • IPO Year
  • BHRB N/A
  • MESO N/A
  • Fundamental
  • Price
  • BHRB $64.20
  • MESO $14.63
  • Analyst Decision
  • BHRB Buy
  • MESO Strong Buy
  • Analyst Count
  • BHRB 2
  • MESO 4
  • Target Price
  • BHRB $77.50
  • MESO $13.50
  • AVG Volume (30 Days)
  • BHRB 43.0K
  • MESO 552.8K
  • Earning Date
  • BHRB 10-25-2024
  • MESO 08-28-2024
  • Dividend Yield
  • BHRB 3.43%
  • MESO N/A
  • EPS Growth
  • BHRB N/A
  • MESO N/A
  • EPS
  • BHRB 1.93
  • MESO N/A
  • Revenue
  • BHRB $181,378,000.00
  • MESO $5,902,000.00
  • Revenue This Year
  • BHRB N/A
  • MESO $66.05
  • Revenue Next Year
  • BHRB $30.90
  • MESO $348.27
  • P/E Ratio
  • BHRB $33.19
  • MESO N/A
  • Revenue Growth
  • BHRB 54.16
  • MESO N/A
  • 52 Week Low
  • BHRB $46.00
  • MESO $1.61
  • 52 Week High
  • BHRB $75.32
  • MESO $19.15
  • Technical
  • Relative Strength Index (RSI)
  • BHRB 35.86
  • MESO 64.37
  • Support Level
  • BHRB $68.60
  • MESO $12.20
  • Resistance Level
  • BHRB $70.85
  • MESO $19.15
  • Average True Range (ATR)
  • BHRB 2.18
  • MESO 0.98
  • MACD
  • BHRB -0.88
  • MESO 0.37
  • Stochastic Oscillator
  • BHRB 8.04
  • MESO 48.93

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. The bank offers a full range of business and personal financial solutions designed to meet customers' banking, borrowing, and investment needs and has over 20 branches throughout the Northern Virginia region and commercial loan offices in Fredericksburg, Loudoun County, and Richmond, Virginia, and in Bethesda, Maryland. The Company operates in one segment which includes Community Banking. The company generates revenue from sources such as Fiduciary and wealth management income, Service charges and fees on deposit accounts consist of monthly service fees, check orders, and other deposit account related fees. Debit card fees and other service charges are primarily comprised of debit and credit card income, ATM fees.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: